Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults

Detalhes bibliográficos
Autor(a) principal: Miyaji, Karina Takesaki
Data de Publicação: 2017
Outros Autores: Avelino-Silva, Vivian Iida, Simões, Marisol, Freire, Marcos da Silva, Medeiros, Carlos Roberto de, Braga, Patrícia Emilia, Neves, Maria Angélica Acalá, Lopes, Marta Heloisa, Kallas, Esper Georges, Sartori, Ana Marli Christovam
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista do Instituto de Medicina Tropical de São Paulo
Texto Completo: https://www.revistas.usp.br/rimtsp/article/view/130557
Resumo: Introduction: The World Health Organization (WHO) recommends one single dose of the Yellow Fever (YF) vaccine based on studies of antibody persistency in healthy adults. We assessed the prevalence and titers of YF virus neutralizing antibodies in previously vaccinated persons aged  60 years, in comparison to younger adults. We also evaluated the correlation between antibody titers and the time since vaccination among participants who received one vaccine dose, and the seropositivity among participants vaccinated prior to or within the past 10 years. Methods: previously vaccinated healthy persons aged  18 years were included. YF virus neutralizing antibody titers were determined by means of the 50% Plaque Reduction Neutralization Test. Results: 46 persons aged  60 years and 48 persons aged 18 to 59 years were enrolled. There was no significant difference in the prevalence of YF virus neutralizing antibodies between the two groups (p = 0.263). However, titers were significantly lower in the elderly (p = 0.022). There was no correlation between YF virus neutralizing antibody titers and the time since vaccination. There was no significant difference in seropositivity among participants vaccinated prior to or within the past 10 years. Conclusions: the clinical relevance of the observed difference in YF virus neutralizing antibody titers between the two groups is not clear.
id IMT-1_13a164603b87ad0bf332b97ef2319156
oai_identifier_str oai:revistas.usp.br:article/130557
network_acronym_str IMT-1
network_name_str Revista do Instituto de Medicina Tropical de São Paulo
repository_id_str
spelling Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adultsElderlyImmunizationNeutralizing antibodySeroprevalenceYellow fever vaccine Introduction: The World Health Organization (WHO) recommends one single dose of the Yellow Fever (YF) vaccine based on studies of antibody persistency in healthy adults. We assessed the prevalence and titers of YF virus neutralizing antibodies in previously vaccinated persons aged  60 years, in comparison to younger adults. We also evaluated the correlation between antibody titers and the time since vaccination among participants who received one vaccine dose, and the seropositivity among participants vaccinated prior to or within the past 10 years. Methods: previously vaccinated healthy persons aged  18 years were included. YF virus neutralizing antibody titers were determined by means of the 50% Plaque Reduction Neutralization Test. Results: 46 persons aged  60 years and 48 persons aged 18 to 59 years were enrolled. There was no significant difference in the prevalence of YF virus neutralizing antibodies between the two groups (p = 0.263). However, titers were significantly lower in the elderly (p = 0.022). There was no correlation between YF virus neutralizing antibody titers and the time since vaccination. There was no significant difference in seropositivity among participants vaccinated prior to or within the past 10 years. Conclusions: the clinical relevance of the observed difference in YF virus neutralizing antibody titers between the two groups is not clear.Universidade de São Paulo. Instituto de Medicina Tropical de São Paulo2017-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/rimtsp/article/view/130557Revista do Instituto de Medicina Tropical de São Paulo; Vol. 59 (2017); e2Revista do Instituto de Medicina Tropical de São Paulo; Vol. 59 (2017); e2Revista do Instituto de Medicina Tropical de São Paulo; v. 59 (2017); e21678-99460036-4665reponame:Revista do Instituto de Medicina Tropical de São Pauloinstname:Instituto de Medicina Tropical (IMT)instacron:IMTenghttps://www.revistas.usp.br/rimtsp/article/view/130557/126915Copyright (c) 2018 Revista do Instituto de Medicina Tropical de São Pauloinfo:eu-repo/semantics/openAccessMiyaji, Karina TakesakiAvelino-Silva, Vivian IidaSimões, MarisolFreire, Marcos da SilvaMedeiros, Carlos Roberto deBraga, Patrícia EmiliaNeves, Maria Angélica AcaláLopes, Marta HeloisaKallas, Esper GeorgesSartori, Ana Marli Christovam2018-02-23T18:46:00Zoai:revistas.usp.br:article/130557Revistahttp://www.revistas.usp.br/rimtsp/indexPUBhttps://www.revistas.usp.br/rimtsp/oai||revimtsp@usp.br1678-99460036-4665opendoar:2022-12-13T16:52:37.796175Revista do Instituto de Medicina Tropical de São Paulo - Instituto de Medicina Tropical (IMT)true
dc.title.none.fl_str_mv Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults
title Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults
spellingShingle Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults
Miyaji, Karina Takesaki
Elderly
Immunization
Neutralizing antibody
Seroprevalence
Yellow fever vaccine
title_short Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults
title_full Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults
title_fullStr Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults
title_full_unstemmed Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults
title_sort Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults
author Miyaji, Karina Takesaki
author_facet Miyaji, Karina Takesaki
Avelino-Silva, Vivian Iida
Simões, Marisol
Freire, Marcos da Silva
Medeiros, Carlos Roberto de
Braga, Patrícia Emilia
Neves, Maria Angélica Acalá
Lopes, Marta Heloisa
Kallas, Esper Georges
Sartori, Ana Marli Christovam
author_role author
author2 Avelino-Silva, Vivian Iida
Simões, Marisol
Freire, Marcos da Silva
Medeiros, Carlos Roberto de
Braga, Patrícia Emilia
Neves, Maria Angélica Acalá
Lopes, Marta Heloisa
Kallas, Esper Georges
Sartori, Ana Marli Christovam
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Miyaji, Karina Takesaki
Avelino-Silva, Vivian Iida
Simões, Marisol
Freire, Marcos da Silva
Medeiros, Carlos Roberto de
Braga, Patrícia Emilia
Neves, Maria Angélica Acalá
Lopes, Marta Heloisa
Kallas, Esper Georges
Sartori, Ana Marli Christovam
dc.subject.por.fl_str_mv Elderly
Immunization
Neutralizing antibody
Seroprevalence
Yellow fever vaccine
topic Elderly
Immunization
Neutralizing antibody
Seroprevalence
Yellow fever vaccine
description Introduction: The World Health Organization (WHO) recommends one single dose of the Yellow Fever (YF) vaccine based on studies of antibody persistency in healthy adults. We assessed the prevalence and titers of YF virus neutralizing antibodies in previously vaccinated persons aged  60 years, in comparison to younger adults. We also evaluated the correlation between antibody titers and the time since vaccination among participants who received one vaccine dose, and the seropositivity among participants vaccinated prior to or within the past 10 years. Methods: previously vaccinated healthy persons aged  18 years were included. YF virus neutralizing antibody titers were determined by means of the 50% Plaque Reduction Neutralization Test. Results: 46 persons aged  60 years and 48 persons aged 18 to 59 years were enrolled. There was no significant difference in the prevalence of YF virus neutralizing antibodies between the two groups (p = 0.263). However, titers were significantly lower in the elderly (p = 0.022). There was no correlation between YF virus neutralizing antibody titers and the time since vaccination. There was no significant difference in seropositivity among participants vaccinated prior to or within the past 10 years. Conclusions: the clinical relevance of the observed difference in YF virus neutralizing antibody titers between the two groups is not clear.
publishDate 2017
dc.date.none.fl_str_mv 2017-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/rimtsp/article/view/130557
url https://www.revistas.usp.br/rimtsp/article/view/130557
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/rimtsp/article/view/130557/126915
dc.rights.driver.fl_str_mv Copyright (c) 2018 Revista do Instituto de Medicina Tropical de São Paulo
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2018 Revista do Instituto de Medicina Tropical de São Paulo
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Instituto de Medicina Tropical de São Paulo
publisher.none.fl_str_mv Universidade de São Paulo. Instituto de Medicina Tropical de São Paulo
dc.source.none.fl_str_mv Revista do Instituto de Medicina Tropical de São Paulo; Vol. 59 (2017); e2
Revista do Instituto de Medicina Tropical de São Paulo; Vol. 59 (2017); e2
Revista do Instituto de Medicina Tropical de São Paulo; v. 59 (2017); e2
1678-9946
0036-4665
reponame:Revista do Instituto de Medicina Tropical de São Paulo
instname:Instituto de Medicina Tropical (IMT)
instacron:IMT
instname_str Instituto de Medicina Tropical (IMT)
instacron_str IMT
institution IMT
reponame_str Revista do Instituto de Medicina Tropical de São Paulo
collection Revista do Instituto de Medicina Tropical de São Paulo
repository.name.fl_str_mv Revista do Instituto de Medicina Tropical de São Paulo - Instituto de Medicina Tropical (IMT)
repository.mail.fl_str_mv ||revimtsp@usp.br
_version_ 1798951651628810240